Cite
HARVARD Citation
Witte, D. et al. (2022). Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study. Lancet infectious diseases. 22 (5), pp. 668-678. [Online].